Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2018-11-26 Report Publication Anno…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Autolus publishes Annual Report
Report Publication Announcement Classification · 99% confidence The document is a press release issued by Syncona Limited, noting that its portfolio company, Autolus Therapeutics plc, has announced the filing of its annual report on Form 20-F for the fiscal year ended 2018 with the SEC. The text explicitly states that the annual report 'can be found on Autolus' investor relations website' and provides a link. Since the document itself is an announcement about the publication of a report (the 20-F, which is equivalent to a 10-K for foreign private issuers) rather than the full report content, and it is distributed via RNS, it fits the definition of a Report Publication Announcement (RPA). The document length (4244 chars) is also short, supporting the RPA classification based on the 'MENU VS MEAL' rule.
2018-11-26 English
Interim Results
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Results' announcement for Syncona Limited for the six months ended 30 September 2018. It contains substantive financial data, including net asset values, portfolio valuations, and management commentary on performance. It is a comprehensive report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2018
2018-11-21 English
Nightstar reports Q3 2018 financial results
Earnings Release Classification · 95% confidence The document is an RNS announcement (RNS Number : 1214H) from Syncona Limited, dated November 13, 2018. The core purpose of the announcement is to note that its portfolio company, Nightstar Therapeutics, has reported its 'Third Quarter 2018 Financial Results' and provided clinical updates. The text contains detailed financial figures for the three and nine months ended September 30, 2018, which is characteristic of a periodic financial report summary. Since this is an announcement by the parent company (Syncona) referencing the quarterly results of a portfolio company (Nightstar), and it contains the actual financial figures rather than just stating the report is available, it aligns best with the 'Interim / Quarterly Report' (IR) category, as it summarizes the results for a period shorter than a year (Q3). It is not merely a 'Report Publication Announcement' (RPA) because it includes the substantive financial data and business highlights, not just a link to the full report. Q3 2018
2018-11-13 English
Autolus Therapeutics to Present New Data at ASH
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated November 1, 2018. It is an announcement by Syncona Limited regarding its portfolio company, Autolus Therapeutics, presenting data at the ASH Annual Meeting. The text includes contact information for RNS and the London Stock Exchange disclaimer, indicating it is a regulatory news service release. Since it is an announcement about future events (presentations) and does not contain comprehensive financial statements (like 10-K or IR) or detailed management analysis (MDA), it fits best as a general regulatory announcement or news release. Given the context of being distributed via RNS, the most appropriate classification is Regulatory Filings (RNS), as it is a general corporate announcement distributed through the official channel.
2018-11-01 English
Freeline releases initial data for FLT180a
Earnings Release Classification · 99% confidence The document begins with 'RNS Number : 0700G' and contains information typical of a regulatory news service announcement from the London Stock Exchange. It details an update from a portfolio company (Freeline) regarding clinical trial data release and an upcoming presentation at a medical conference (ASH). This type of broad, timely corporate disclosure that doesn't fit neatly into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing or Regulatory News Service announcement. Given the options, 'RNS' (Regulatory Filings) is the most appropriate fallback category for this type of market-sensitive, non-standardized announcement. Q1 2018
2018-11-01 English
Director Information
Board/Management Information Classification · 98% confidence The document is identified by the header 'RNS Number : 8886F' and explicitly states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content details the appointment of a Non-Executive Director (Robert Hutchinson) to another company's board. This type of announcement regarding changes in senior management or board composition directly corresponds to the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is MANG, which takes precedence over the general RNS fallback.
2018-11-01 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.